Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac Trial
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer Ingelheim must pay damages to an Illinois man who …
Source: Claims Journal